High-dose-rate brachytherapy for large prostate volumes (≥50 cc)-Uncompromised dosimetric coverage and acceptable toxicity

Large prostate volume is not a contraindication to HDR brachytherapy. Excellent dosimetric coverage can be attained with acceptable acute toxicity.